Ann Surg Oncol. 2022 Feb 12. doi: 10.1245/s10434-021-11286-2. Online ahead of print.
NO ABSTRACT
PMID:35152359 | DOI:10.1245/s10434-021-11286-2
Categories
ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis
